https://www.orthoworld.com
ORTHOWORLD
Anika Therapeutics Reports 3Q18 Revenue of $24.1MM, +0.4% vs. 3Q17
By Mike Evers
Anika Therapeutics posts 3Q18 orthobiologic revenue of $24.1MM, +0.4% vs. 3Q17.
Empowering Orthopaedic Executives through Strategic Intelligence
By Mike Evers
Product Labels: Viscosupplement
Tags: Revenue Report